Our Impact

Cure SMA’s New Year Letter for 2021

January 1, 2021
Posted in ,

Dear SMA Community, While 2020 did not pan out as we had expected, Cure SMA remains extremely optimistic about the future for our community in […]

Read More ›

Cure SMA, Novartis Publish Economic Burden of SMA Analysis in Journal of Market Access & Health Policy

December 14, 2020
Posted in , ,

Recently, Cure SMA and colleagues at Novartis Gene Therapies published a manuscript titled, “Economic burden of spinal muscular atrophy: an analysis of claims data” in […]

Read More ›

Results from Annual SMA Community Update Survey Now Published

November 5, 2020
Posted in , ,

Each year since 2017, Cure SMA has conducted a Community Update Survey. This online questionnaire is sent to all individuals with spinal muscular atrophy (SMA) […]

Read More ›

Annual Cure SMA Community Update Survey Ready for Your Input

April 23, 2020
Posted in , ,

Navigating the recent global health crisis, Coronavirus (COVID-19), has reinforced for us the importance of understanding what the SMA community is thinking, feeling, and experiencing. […]

Read More ›

Cure SMA Launches “Spotlight on SMA” Partnership with Neurology Reviews

February 11, 2020
Posted in , ,

Cure SMA is pleased to announce the release of “Spotlight on SMA: The Urgent Need for Early Diagnosis in Spinal Muscular Atrophy,” a supplement developed […]

Read More ›

Cure SMA Establishes an Adult Advisory Council

October 28, 2019
Posted in ,

We are happy to announce the establishment of the Adult Advisory Council. The Adult Advisory Council is a volunteer council that provides guidance, advice, and […]

Read More ›

Cure SMA Awards Grants to Four States to Expediate the Implementation of SMA Newborn Screening

August 13, 2019
Posted in , ,

On July 3, 2018, Health and Human Services Secretary Alex Azar approved the recommendation that newborn screening for spinal muscular atrophy be implemented nationwide. This recommendation was […]

Read More ›

Updated SMA Drug Pipeline Now Available

June 28, 2019
Posted in , ,

We’ve recently released an update to the SMA drug pipeline. This latest version includes: 23 active programs, including two approved therapies. 15 pharmaceutical partners. 6 […]

Read More ›

Cure SMA Awards $150,000 Grant to Krysta Engel, PhD, University of Colorado

May 21, 2019
Posted in , ,

Audrey Lewis founded Families of SMA, now Cure SMA, 34 years ago. Audrey recognized early on the importance of attracting new and talented researchers to […]

Read More ›

Spring 2019 SMA Newborn Screening Update

May 13, 2019
Posted in , ,

We are thrilled to announce that Missouri, Pennsylvania and Vermont have now implemented permanent statewide SMA newborn screening, making 6 states that are now permanently […]

Read More ›
Scroll to Top